13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-09-26 Event 2025-09-24 SEC 0001213900-25-092516 →

BROADWOOD PARTNERS, L.P. STAAR SURGICAL CO STAA

Stake: 27.40% Shares: 13,545,391 CUSIP: 852312305 Class: Common Stock, par value $0.01 per share

Item 4 — Purpose of Transaction

Item 4 is hereby amended and supplemented by the addition of the following: On September 24, 2025, the Reporting Persons filed a definitive proxy statement (the "Definitive Proxy Statement") and accompanying GREEN Proxy Card with the SEC to solicit proxies for the purpose of voting "AGAINST" the Proposed Merger in connection with the Merger Agreement at the Special Meeting. At the Special Meeting, the Reporting Persons will oppose stockholder approval of the (i) Merger Agreement Proposal and (ii) Compensation Proposal. Details of the Merger Agreement Proposal, including information about the Reporting Persons reasons for opposing the Proposed Merger, can be found in the Definitive Proxy Statement, which is available at no charge on the SEC's website at http://www.sec.gov. Also on September 24, 2025, the Reporting Persons issued a press release, containing a letter to stockholders of the Issuer (the "September 24 Letter"). In the September 24 Letter, the Reporting Persons announced the launch of their campaign website, www.LetSTAARShine.com, and stated that, in their view, the Proposed Merger is a suboptimal transaction because it was (i) agreed to at an inopportune time, (ii) the result of a flawed process and (iii) influenced by a conflicted Board and management team. The foregoing description of the September 24 Letter does not purport to be complete and is qualified in its entirety by reference to the full text of the September 24 Letter, which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The Reporting Persons are asking stockholders to vote on their GREEN Proxy Card "AGAINST" the Merger Agreement Proposal and "AGAINST" the Compensation Proposal.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
12 13D/G filings on this issuer
11 other filings besides this one
Filer Track Record
22 filings by this filer
21 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 5.63
7,730,427 shares short · +10.2% vs prior

Other 13D/G Filings on STAAR SURGICAL CO

FiledFormFilerStakeShares
2026-01-08 SCHEDULE Yunqi Capital Ltd 6.50% 3,257,130 view →
2025-11-03 SCHEDULE Yunqi Capital Ltd 5.10% 2,500,061 view →
2025-09-02 SCHEDULE BROADWOOD PARTNERS, L.P. 27.30% 13,545,391 view →
2025-04-02 SCHEDULE BROADWOOD PARTNERS, L.P. 25.40% 12,512,944 view →
2025-03-03 SCHEDULE BROADWOOD PARTNERS, L.P. 24.30% 11,979,098 view →
2024-01-10 SC BROADWOOD PARTNERS, L.P. view →
2023-10-10 SC BROADWOOD PARTNERS, L.P. view →
2021-10-01 SC BROADWOOD PARTNERS, L.P. view →
2021-06-16 SC BROADWOOD PARTNERS, L.P. view →
2021-04-05 SC BROADWOOD PARTNERS, L.P. view →
2020-08-12 SC BROADWOOD PARTNERS, L.P. view →

Other Filings by BROADWOOD PARTNERS, L.P.

FiledFormIssuerStakeShares
2025-09-02 SCHEDULE STAAR SURGICAL CO STAA 27.30% 13,545,391 view →
2025-04-02 SCHEDULE STAAR SURGICAL CO STAA 25.40% 12,512,944 view →
2025-03-03 SCHEDULE STAAR SURGICAL CO STAA 24.30% 11,979,098 view →
2025-02-10 SCHEDULE Oncocyte Corp IMDX 40.20% 11,560,350 view →
2025-01-28 SCHEDULE Lineage Cell Therapeutics, Inc. LCTX 24.50% 57,848,357 view →
2024-01-10 SC STAAR SURGICAL CO STAA view →
2023-10-10 SC STAAR SURGICAL CO STAA view →
2022-04-15 SC Oncocyte Corp IMDX view →
2021-10-01 SC STAAR SURGICAL CO STAA view →
2021-09-24 SC Oncocyte Corp IMDX view →
2021-06-16 SC STAAR SURGICAL CO STAA view →
2021-04-05 SC STAAR SURGICAL CO STAA view →
2021-03-16 SC Lineage Cell Therapeutics, Inc. LCTX view →
2021-02-09 SC OncoCyte Corp IMDX view →
2021-01-22 SC OncoCyte Corp IMDX view →
2020-08-12 SC STAAR SURGICAL CO STAA view →
2019-09-13 SC OncoCyte Corp IMDX view →
2019-07-02 SC OncoCyte Corp IMDX view →
2019-03-12 SC Asterias Biotherapeutics, Inc. view →
2019-03-12 SC BIOTIME INC LCTX view →
Showing 20 of 21

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →